Oncology & Cancer

Personalizing cancer treatment through machine learning

Researchers at the Cheriton School of Computer Science have applied machine learning to identify tumor-specific antigens, which could help make personalized cancer vaccines practically feasible and more accurate.

Diseases, Conditions, Syndromes

Promoting mixed chimerism promising in kidney transplants

(HealthDay)—For patients undergoing living kidney transplants, persistent mixed chimerism can be achieved to allow complete or partial withdrawal of immunosuppressive drugs, according to a study published in the Jan. 29 ...

Oncology & Cancer

Allo-HCT with unrelated donor tied to better outcomes in AML

(HealthDay)—Allogeneic hematopoietic cell transplantation (allo-HCT) with an unrelated donor (UD) results in better transplantation outcomes than cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients ...

Genetics

Keeping aging brains healthy—lessons from genes

Do any genes protect against Alzheimer's disease? And do any predispose a person to its ravages? The answer is yes to both, according to work led by U of M researcher Lisa James.

Diseases, Conditions, Syndromes

A risk factor for drug-induced skin disease identified

DPP-4 inhibitor (DPP-4i) is widely used to treat type 2 diabetes, but increased cases of bullous pemphigoid (BP) have been reported among patients taking the medicine. BP is the most common autoimmune blistering disorder, ...

Immunology

Countering atopic dermatitis immune reactions

Human leukocyte antigen (HLA)-G is a protein that interacts with specific cell receptors to inhibit immune responses. The protein is best known for its role in protecting the fetus from attack by its mother's immune system. ...

page 4 from 7